Smith & Nephew SNATS Inc (SNN) · Peers
Smith & Nephew SNATS against the 25 other companies here in its SEC industry, Orthopedic, Prosthetic & Surgical Appliances & Supplies. Each figure is the one on the company's own page; the median is the peers', and the rank is among all 26, highest first.
Measure by measure
| Measure | SNN | Peer median | Rank |
|---|---|---|---|
| Market value | $12.16B | median $153.22M | 5 of 26 |
| P/E | 19.5× | median 27.0× | 9 of 10 |
| Forward P/E | 13.1× | median 19.7× | 8 of 10 |
| EV/EBITDA | 18.9× | median 15.0× | 5 of 12 |
| P/S | 2.0× | median 2.8× | 17 of 25 |
| FCF yield | 7.0% | median -2.4% | 3 of 26 |
| Dividend yield | 2.7% | median 1.2% | 2 of 7 |
| Gross margin | 68.0% | median 56.5% | 10 of 25 |
| Operating margin | 12.9% | median -4.4% | 7 of 22 |
| Net margin | 10.1% | median -10.9% | 5 of 22 |
| ROIC | 7.7% | median -7.0% | 10 of 24 |
| ROE | 11.8% | median -44.2% | 3 of 25 |
| Revenue growth (4y, yearly) | 4.3% | median 8.2% | 14 of 23 |
| EPS growth (yearly) | 4.6% | median 15.4% | 6 of 9 |
| Net debt / EBITDA | 3.6× | median 2.9× | 2 of 7 |
| Current ratio | 2.6× | median 2.5× | 13 of 26 |
| Stock pay / revenue | 0.7% | median 3.1% | 22 of 25 |
| Share count change | -0.3% | median 5.2% | 20 of 26 |
Green where Smith & Nephew SNATS is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.
The peers, largest first
| Company | Market value | P/E | ROIC | Score |
|---|---|---|---|---|
| SNNSmith & Nephew SNATS Inc | $12.16B | P/E 19.5× | 7.7% | 6.9 |
| ISRGIntuitive Surgical Inc | $150.74B | P/E 48.0× | 21.1% | 7.3 |
| EWEdwards Lifesciences Corp | $49.92B | P/E 49.7× | 16.4% | 6.5 |
| STESTERIS plc | $21.71B | P/E 27.0× | 10.5% | 7.2 |
| ZBHZimmer Biomet Holdings Inc | $18.12B | P/E 22.5× | 4.8% | 6.6 |
| ALGNAlign Technology Inc | $10.46B | P/E 25.3× | 13.8% | 6.7 |
| MSAMSA Safety Inc | $6.91B | P/E 22.0× | 18.0% | 7.5 |
| ESTAEstablishment Labs Holdings Inc. | $1.76B | P/E – | -7.0% | 3.9 |
| ENOVEnovis CORP | $1.13B | P/E – | -29.4% | 4.4 |
| CDRECadre Holdings, Inc. | $1.12B | P/E 31.0× | 8.1% | 6.5 |
| AVRAnteris Technologies Global Corp. | $589.62M | P/E – | -4339.4% | 3.3 |
| SMTISanara MedTech Inc. | $304.68M | P/E – | 17.1% | 4.9 |
| INGNInogen Inc | $165.86M | P/E – | -35.2% | 5.2 |
| ZJYLJin Medical International Ltd. | $153.22M | P/E 128.6× | 5662.5% | 3.8 |
| LAKELakeland Industries Inc | $90.11M | P/E – | -4.9% | 4.1 |
| NTRBNutriBand Inc. | $74.08M | P/E – | -305.0% | 2.9 |
| APTAlpha Pro Tech Ltd | $56.64M | P/E 13.5× | 8.0% | 7.0 |
| COCHEnvoy Medical, Inc. | $50.95M | P/E – | – | 2.1 |
| MYOMyomo, Inc. | $49.11M | P/E – | -203.0% | 5.0 |
| MLSSMilestone Scientific Inc. | $28.74M | P/E – | -139.8% | 4.6 |
| CUPRCuprina Holdings (Cayman) LTD | $26.96M | P/E – | -178.2% | 2.6 |
| LFWDLifeward Ltd. | $17.56M | P/E – | -649.3% | 5.0 |
| UEECUnited Health Products, Inc. | $13.40M | P/E – | – | 2.2 |
| CLGNCollPlant Biotechnologies Ltd | $6.71M | P/E – | -1851.3% | 4.6 |
| FEEDENvue Medical, Inc. | $4.11M | P/E – | -69.9% | 3.3 |
| LGMKLogicMark, Inc. | $1.17M | P/E – | -77.9% | 4.6 |
The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.